AURA Projected Dividend Yield
Aura Biosciences Inc ( NASDAQ : AURA )Aura Biosciences, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing precision immunotherapies to treat solid tumors designed to preserve the function of the afflicted organ with cancer. It is developing a pipeline of virus-like drug conjugates (VDCs), a class of drugs with a dual mechanism of action, that promote cancer cell death by both the delivery of the cytotoxic payload to generate acute necrosis and activation of a secondary immune mediated response. 21 YEAR PERFORMANCE RESULTS |
AURA Dividend History Detail AURA Dividend News AURA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |